Cover image for Signaling Pathways in Liver Diseases.
Signaling Pathways in Liver Diseases.
Title:
Signaling Pathways in Liver Diseases.
Author:
Dufour, Jean-Francois.
ISBN:
9781118663356
Personal Author:
Edition:
3rd ed.
Physical Description:
1 online resource (520 pages)
Contents:
Title Page -- Copyright Page -- Contents -- List of Contributors -- Chapter 1 Hepatocytes -- Introduction -- Liver and hepatocyte development -- Phenotype and regeneration of the mature hepatocyte -- Metabolic functions of the liver -- Resorption, storage, and synthesis -- Detoxification and excretion -- Detoxification of specific substances -- Excretion -- Multiple choice questions -- References -- Chapter 2 Signaling pathways in biliary epithelial cells -- Introduction -- Membrane receptors -- Cyclic adenosine 3', 5'-monophosphate (cAMP) -- Cytosolic Ca2+ -- Protein kinase C -- Mitogen-activated protein kinase signaling -- Phosphotidylinositol 3-kinase signaling -- Notch signaling -- Hedgehog signaling -- Vascular endothelial growth factor -- Pathological conditions -- Conclusion -- Acknowledgments -- Multiple choice questions -- References -- Chapter 3 Stellate cells -- Polypeptide growth factor receptors -- Transforming growth factor-β receptor superfamily -- Seven transmembrane domain receptors -- Chemokines -- Tumor necrosis factor receptor superfamily -- Nuclear receptor family -- Other cytokine receptors -- Adipokine receptors -- Extracellular matrix signaling and hepatic stellate cells -- Toll-like receptors -- Cannabinoid receptors -- Hedgehog pathway -- Wnt pathway -- Autophagy -- Senescence of activated stellate cells -- miRNAs and hepatic stellate cells -- Conclusion -- Multiple choice questions -- References -- Chapter 4 Kupffer cells -- Introduction -- Markers, origin, and heterogeneity of Kupffer cells -- M1 versus M2 polarization in Kupffer cells -- Lipopolysaccharide signaling and endotoxin tolerance -- Experimental approaches to deplete Kupffer cells in vivo -- Role of Kupffer cells in liver disease -- Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis -- Alcoholic liver disease -- Liver regeneration.

Liver fibrosis and cirrhosis -- Ischemia-reperfusion liver injury -- Primary and metastatic liver tumors -- Infectious diseases -- Clinical applications and future perspectives -- Acknowledgment -- Multiple choice questions -- References -- Chapter 5 Hepatic sinusoidal endothelial cells -- Development and structure -- Cellular functions -- Filtration via fenestrae -- Diapedesis -- Nitric oxide signaling -- Endocytosis -- Bacterial processing -- Liver regeneration -- Pathobiology -- Fibrosis and cirrhosis -- Alcoholic liver disease -- Nonalcoholic fatty liver disease -- Hepatic malignancies -- Drug toxicity -- Ischemia-reperfusion injury -- Aging process -- Conclusion -- Multiple choice questions -- References -- Chapter 6 Extracellular matrix -- Introduction -- Components of the extracellular matrix in liver (Figure 6.1) -- The collagen scaffold -- Proteoglycans -- Laminin -- Fibronectin -- Matricellular proteins -- Changes in the extracellular matrix from normal to fibrotic liver -- Pathways of cell-matrix interaction -- Integrin family -- ADAM molecules -- Discoidin domain receptors -- Growth factors in ECM (Figure 6.4) -- The extracellular matrix and the stem cell niche -- Metalloproteinases and their inhibitors -- Conclusion -- Multiple choice questions -- References -- Chapter 7 Platelets: a new cell type in liver physiology -- What are platelets? -- Ischemia/reperfusion injury -- Cold ischemia -- Warm ischemia -- Liver regeneration -- Role of platelets -- Role of platelet-derived serotonin -- Platelets in chronic liver disease -- Alterations in platelets in patients with liver disease -- Platelet involvement in liver diseases -- Conclusion -- Multiple choice questions -- References -- Chapter 8 Immune cell communication in liver disease and liver regeneration -- Introduction -- The innate immune system within the liver -- Dendritic cells.

Natural killer cells, tatural killer T cells, and Tγδ cells -- Adaptive immunity within the liver -- T cells -- B cells -- Regulation of the immune response -- Immune cell function in liver disease -- Liver transplantation -- Autoimmune liver disease -- Alcoholic liver disease -- Hepatic immune cell function during liver regeneration -- Multiple choice questions -- References -- Chapter 9 Extracellular vesicle RNA in liver disease -- Introduction -- Types of extracellular RNA -- Classification of extracellular vesicles -- Contents of extracellular vesicles -- Assessment of extracellular vesicle RNA -- Biological roles of extracellular vesicle RNA -- Pathophysiological roles of extracellular vesicle RNA in liver disease -- Hepatocellular cancer -- Tissue injury -- Viral hepatitis -- Translational implications -- Conclusion -- Acknowledgments -- Multiple choice questions -- References -- Chapter 10 Endoplasmic reticulum stress in nonalcoholic fatty liver disease -- Endoplasmic reticulum -- Smooth endoplasmic reticulum -- Rough endoplasmic reticulum -- Unfolded protein response -- PKR-like ER kinase (PERK) -- Inositol requiring enzyme 1 (IRE1) -- ATF6 transcription factor -- ER stress and apoptosis -- The UPR and human diseases -- Role of the unfolded protein response in liver physiology and physiopathology -- Role of UPR in liver physiology -- Role of UPR in NAFLD -- Targeting the unfolded protein response to treat nonalcoholic fatty liver disease -- Multiple choice questions -- References -- Chapter 11 Autophagy -- Introduction -- Autophagy pathways and regulations -- Autophagy molecules and autophagosome biogenesis -- Regulation of autophagy by metabolic and stress pathways -- Autophagy and liver diseases -- Autophagy and viral hepatitis -- Autophagy and hepatic cancer -- Autophagy and alcoholic/nonalcoholic fatty liver disease.

Autophagy in liver injury -- Autophagy in liver fibrosis -- Autophagy and α1-antitrypsin deficiency -- Conclusion -- Multiple choice questions -- References -- Chapter 12 CXC chemokine receptor signaling in liver repair and regeneration -- Introduction -- Mediators of liver regeneration -- CXC chemokine ligands and receptors -- Impact of CXC chemokines on liver repair and regeneration -- ELR+ CXC chemokines -- ELR- CXC chemokines -- Conclusion -- Multiple choice questions -- References -- Chapter 13 Metabolic regulation of liver regeneration -- Introduction -- Hepatic insufficiency-induced alterations in metabolism -- Metabolic regulation of liver regeneration -- Metabolic and regenerative responses to PH are proportionate -- Glucose supplementation impairs regeneration -- Disrupting hepatic fat accumulation suppresses regeneration -- Amino acid metabolism and regemneration -- Regenerative regulation of metabolism -- Candidate mechanisms linking metabolism and regeneration -- Xenobiotic-activated nuclear hormone receptor-dependent hepatocellular proliferation -- Metabolism and epigenetic regulation during regeneration -- A metabolic model of liver regeneration -- Clinical implications -- Fatty liver -- Aging -- Subtotal hepatectomy -- Metabolomic biomarkers of human liver regeneration -- Conclusions -- Acknowledgments -- Multiple choice questions -- References -- Chapter 14 TNF signaling -- Introduction -- TNF: molecules and structure -- TNF signaling pathways -- Signal transduction by TNFR1 -- Signal transduction by TNFR2 -- Amplification and inhibition of the death signal -- c-Jun N-terminal kinase -- TNF signaling - switching apoptosis to necrosis -- Function of TNF signaling in hepatic pathophysiology -- Liver regeneration -- Toxin-induced liver injury -- Nonalcoholic steatohepatitis -- Viral hepatitis -- Conclusion -- Acknowledgments.

Multiple choice questions -- References -- Chapter 15 Fas/FasL -- Introduction -- Fas (CD95/APO-1) and Fas ligand (FasL/CD95L) -- Fas (CD95/APO-1) -- Fas ligand (FasL/CD95L) -- Fas/FasL apoptotic signaling -- Fas/FasL noncytotoxic signaling -- Fas/FasL in liver diseases -- Pathological conditions associated with reduced Fas-mediated apoptosis -- Pathologic conditions associated with excessive Fas-mediated apoptosis -- Multiple choice questions -- References -- Chapter 16 Interferon signaling -- Interferons -- Induction of type I interferons -- Interferon signaling through the Jak-STAT pathway -- The receptor-kinase complex -- Signal transducers and activators of transcription -- Negative regulators of interferon signaling -- Refractoriness of interferon signaling -- Effects of type I interferons -- Interferon regulated genes -- Antiviral effects -- Antiproliferative effects -- Interferon signaling in viral hepatitis -- Interference of hepatitis C virus with interferon signaling -- Hepatitis C virus-induced activation of the interferon system -- Interferon signaling in chronic hepatitis B -- Interferon signaling in chronic hepatitis D -- Multiple choice questions -- References -- Chapter 17 Endocannabinoid signaling in liver pathologies -- Endocannabinoids -- The endocannabinoid system -- Endocannabinoid synthesis -- Endocannabinoid degradation -- The complex relationships of the endocannabinoid system -- Growing list of potential eCBs and eCB-like lipids -- Alternative paths of eCB degradation and cross-over with other lipid signaling systems -- Affinities of eCBs for CNRs and beyond -- Signaling downstream of the CNRs -- Nonalcoholic fatty liver disease -- Alcoholic fatty liver -- Progression to steatohepatitis -- Liver fibrosis -- Ischemia/reperfusion injury -- Regeneration -- Hepatitis C -- Hepatocellular carcinoma -- Conclusion.

Multiple choice questions.
Abstract:
Signaling Pathways in Liver Diseases, Third Edition again provides hepatologists and hepatology researchers with an expert overview of the complex and novel cellular/extracellular signaling pathways in the liver, and their role in liver diseases. The last few years have seen a great number of developments in this field, which in turn have led to new opportunities for innovative treatments; however, the intricacy of these pathways and their interactions continue to provide a real challenge for clinicians. This outstanding book compiles the emerging knowledge into a single expert resource, cataloguing and organizing it into an accessible and understandable format. With increased focus on the comprehension of cellular mechanisms involved in steatohepatitis, cirrhosis, and liver tumors, which has led to changes in the management of these diseases, this new edition also sees the introduction of exciting new chapters on key emerging areas such as: Autophagy Notch Pathway P13K/PTEN Signaling in Liver Diseases Sirtuins Hepcidin and Iron Epigenetic Regulation of Hepatic Stellate Cells and Liver Fibrosis Oxidative Stress and Signaling in the Liver. Professors Dufour and Clavien have assembled an all-star cast of chapter authors, each of whom has provided clear and appropriate illustrations to reinforce the text, with a key points box offering a concise and handy summary. Self-assessment questions and answers allow the reader to test their own knowledge. Signaling Pathways in Liver Disease, Third Edition is the perfect educational and reference tool to bridge the information exchange between the laboratory, the clinical ward, and the operating room, and an essential tool for the modern-day hepatologist.
Local Note:
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2017. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
Added Author:
Electronic Access:
Click to View
Holds: Copies: